Evidence map›Paper›PMID 34671928›Full record

ArticleMolecular imaging and biology2022

Alexander H J Staal, Andor Veltien, Mangala Srinivas, Tom W J Scheenen

Abstract read
In one paragraph

Article in Molecular imaging and biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alexander H J StaalTumor Immunology Lab, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, the Netherlands.
Andor VeltienDepartment of Medical Imaging, Radboudumc, Nijmegen, the Netherlands.
Mangala SrinivasTumor Immunology Lab, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, the Netherlands.
Tom W J ScheenenDepartment of Medical Imaging, Radboudumc, Nijmegen, the Netherlands. tom.scheenen@radboudumc.nl.ORCID http://orcid.org/0000-0002-4468-1480

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeIsoflurane (ISO) is the most commonly used preclinical inhalation anesthetic. This is a problem in PROCEDURES: Three strategies to avoid ISO chemical shift displacement artifacts (CSDA) in

resultsAll three strategies result in complete ISO signal avoidance (p < 0.0001 for all methods). Using a narrow acquisition bandwidth can result in loss of signal to noise ratio and distortion of the image, and a frequency-selective suppression pulse can be incomplete when B

conclusionWe optimized three easily implementable methods to avoid ISO signal artifacts and validated their performance in phantoms and in vivo. We make recommendation on the parameters that pre-clinical studies should report in their method section to make the used approach insightful.

Indexed as

ArtifactsIsofluraneContrast MediaMagnetic Resonance ImagingPhantoms, ImagingReproducibility of ResultsContrast MediaIsofluraneAnesthesiaArtifactsChemical shiftFluorine-19 Magnetic Resonance ImagingImagingIsoflurane

Identifiers

PMID34671928
PMCPMC8760223

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.